Bruker (BRKR) reported Q3 non-GAAP earnings Tuesday of $0.60 per diluted share, down from $0.74 a year earlier.
Analysts polled by Capital IQ expected $0.60 per share.
Revenue in the quarter ended Sept. 30 was $864.4 million, up from $742.8 million a year earlier.
Analysts surveyed by Capital IQ expected $866.1 million.
The company lowered its outlook for 2024 non-GAAP EPS to $2.36 to $2.41, from $2.59 to $2.64 previously. Analysts surveyed by Capital IQ expect $2.60.
Bruker expects 2024 revenue of $3.34 billion to $3.37 billion, compared with $3.38 billion and $3.44 billion previously. Analysts polled by Capital IQ expect $3.40 billion.
Bruker shares fell by more than 6% in premarket trading.
Price: 55.99, Change: -3.36, Percent Change: -5.66
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。